Skip to main content
Top
Published in:

Open Access 01-12-2024 | Case Report

Paracetamol overdose associated with cortical blindness-complicated acute leukoencephalopathy: a case report

Authors: Ruba Khasawneh, Nour Keewan, Samah K. Aburahma, Basel Waleed Khurfan

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2024

Login to get access

Abstract

Background

Paracetamol is one of the most used antipyretics and analgesics among pediatrics, and its overdose is highly encountered among pediatrics especially in the pre-school age. While it is well-known that paracetamol overdose may lead to toxicities including severe hepatic toxicity, some recent reports have highlighted its “in situ” toxicity on brain tissue at high doses, even in the absence of hepatotoxicity. This can result in acute leukoencephalopathy (AL), coma, or even death. This report describes a case of a child who developed cortical blindness-complicated AL, following a paracetamol overdose.

Case presentation

An 18-month-old previously healthy girl accidentally ingested 300 mg/kg of paracetamol suspension. After ingestion, the child was in an initial bad condition that has gradually improved. Several days after ingestion, the patient lost her vision, and she remained blind since then despite a newer appreciation to light. The initial brain magnetic resonance imaging (MRI) suggested AL demonstrated as a faint high T2/fluid-attenuated inversion recovery (FLAIR) signal intensity in the cortical and subcortical regions of both parieto-occipital lobes with sulcal effacement and restricted diffusion. After around 3 months, the subsequent brain MRI showed involutional changes that were manifested as a brain volume loss in the same areas with evidence of gyri-form laminar necrosis in both parieto-occipital regions without restricted diffusion. Other brain MRI findings include right cerebral convexity hyperacute subdural hematoma with prominent subarachnoid spaces.

Conclusions

The child developed cortical blindness-complicated AL following a paracetamol overdose. It is well- known that AL may result from several toxins by their direct and/or indirect effect on the cerebral white matter. However, there is still no enough data in the literature clearly explaining the relation of paracetamol overdose to AL. The generally proposed effect of paracetamol on the brain is mainly justified by the excessive oxidative stress. Further studies at the cellular and genetic levels are still needed to investigate the exact association between paracetamol overdose and AL, as well as the underlying mechanisms involved.
Literature
1.
go back to reference Locci C, Cuzzolin L, Capobianco G, Antonucci R. Paracetamol overdose in the newborn and infant: a life-threatening event. Eur J Clin Pharmacol. 2021;77(6):809–15.CrossRefPubMed Locci C, Cuzzolin L, Capobianco G, Antonucci R. Paracetamol overdose in the newborn and infant: a life-threatening event. Eur J Clin Pharmacol. 2021;77(6):809–15.CrossRefPubMed
2.
go back to reference Kominek K, Pawlowska-Kamieniak A, Mroczkowska-Juchkiewicz A, Krawiec P, Pac-Kozuchowska E. Intentional and accidental paracetamol poisoning in childhood—a retrospective analysis. Postepy Hig Med Dosw. 2015;69:452–6.CrossRef Kominek K, Pawlowska-Kamieniak A, Mroczkowska-Juchkiewicz A, Krawiec P, Pac-Kozuchowska E. Intentional and accidental paracetamol poisoning in childhood—a retrospective analysis. Postepy Hig Med Dosw. 2015;69:452–6.CrossRef
3.
go back to reference Tong HY, Medrano N, Borobia AM, Ruiz JA, Martinez AM, Martin J, et al. Hepatotoxicity induced by acute and chronic paracetamol overdose in children: where do we stand? World J Pediatr. 2017;13(1):76–83.CrossRefPubMed Tong HY, Medrano N, Borobia AM, Ruiz JA, Martinez AM, Martin J, et al. Hepatotoxicity induced by acute and chronic paracetamol overdose in children: where do we stand? World J Pediatr. 2017;13(1):76–83.CrossRefPubMed
4.
go back to reference Przybyla GW, Szychowski KA, Gminski J. Paracetamol—an old drug with new mechanisms of action. Clin Exp Pharmacol Physiol. 2021;48(1):3–19.CrossRefPubMed Przybyla GW, Szychowski KA, Gminski J. Paracetamol—an old drug with new mechanisms of action. Clin Exp Pharmacol Physiol. 2021;48(1):3–19.CrossRefPubMed
5.
go back to reference Cairns R, Brown JA, Wylie CE, Dawson AH, Isbister GK, Buckley NA. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004–2017. Med J Aust. 2019;211(5):218–23.CrossRefPubMed Cairns R, Brown JA, Wylie CE, Dawson AH, Isbister GK, Buckley NA. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004–2017. Med J Aust. 2019;211(5):218–23.CrossRefPubMed
6.
go back to reference Dan-Nielsen S, Bisgaard AS, Jans SR, Arianto L, Heedeland RL, Jorgensen MH. Retrospective study of paracetamol poisoning in children aged zero to six years found no cases of liver injury. Acta Paediatr. 2018;107(10):1775–80.CrossRefPubMed Dan-Nielsen S, Bisgaard AS, Jans SR, Arianto L, Heedeland RL, Jorgensen MH. Retrospective study of paracetamol poisoning in children aged zero to six years found no cases of liver injury. Acta Paediatr. 2018;107(10):1775–80.CrossRefPubMed
7.
go back to reference Sia J, Chan Y. Case report: paracetamol poisoning in a 2-year-old child—from international overview to the role of the Hong Kong Poison Information Centre. Hong Kong J Emerg Med. 2006;13(4):225–31.CrossRef Sia J, Chan Y. Case report: paracetamol poisoning in a 2-year-old child—from international overview to the role of the Hong Kong Poison Information Centre. Hong Kong J Emerg Med. 2006;13(4):225–31.CrossRef
9.
go back to reference Wiegand TJ, Margaretten M, Olson KR. Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol. 2010;48(2):156–9.CrossRef Wiegand TJ, Margaretten M, Olson KR. Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafiltration. Clin Toxicol. 2010;48(2):156–9.CrossRef
10.
go back to reference Ghanem CI, Perez MJ, Manautou JE, Mottino AD. Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016;109:119–31.CrossRefPubMedPubMedCentral Ghanem CI, Perez MJ, Manautou JE, Mottino AD. Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016;109:119–31.CrossRefPubMedPubMedCentral
11.
go back to reference Essawy AE, Alkhuriji AF, Soffar AA. Paracetamol overdose induces physiological and pathological aberrations in rat brain. J Appl Pharm Sci. 2017;7(9):185–90. Essawy AE, Alkhuriji AF, Soffar AA. Paracetamol overdose induces physiological and pathological aberrations in rat brain. J Appl Pharm Sci. 2017;7(9):185–90.
12.
go back to reference Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–87.CrossRefPubMed Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777–87.CrossRefPubMed
13.
go back to reference Ara K, Ahmad K. Uptake of paracetamol into brain and liver of rats. Bangladesh Med Res Counc Bull. 1980;6(2):39–44.PubMed Ara K, Ahmad K. Uptake of paracetamol into brain and liver of rats. Bangladesh Med Res Counc Bull. 1980;6(2):39–44.PubMed
14.
go back to reference Kalyanshettar S, Patil SV, Prakash VJ, Mahaldar A, Teggi P. A case of ALERD masquerading as paracetamol poisoning. J Nepal Paediatr Soc. 2020;40(3):261–4.CrossRef Kalyanshettar S, Patil SV, Prakash VJ, Mahaldar A, Teggi P. A case of ALERD masquerading as paracetamol poisoning. J Nepal Paediatr Soc. 2020;40(3):261–4.CrossRef
15.
go back to reference Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med. 2001;345(6):425–32.CrossRefPubMed Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med. 2001;345(6):425–32.CrossRefPubMed
16.
go back to reference Wheaton T, Toll BJ, Breznak K, Da-Silva S, Melvin J, Misra A, et al. Opioid-induced toxic leukoencephalopathy: a case report and review of the literature. Heliyon. 2019;5(12): e03005.CrossRefPubMedPubMedCentral Wheaton T, Toll BJ, Breznak K, Da-Silva S, Melvin J, Misra A, et al. Opioid-induced toxic leukoencephalopathy: a case report and review of the literature. Heliyon. 2019;5(12): e03005.CrossRefPubMedPubMedCentral
17.
go back to reference Ozutemiz C, Roshan SK, Kroll NJ, Benson JC, Rykken JB, Oswood MC, et al. Acute toxic leukoencephalopathy: etiologies, imaging findings, and outcomes in 101 patients. AJNR Am J Neuroradiol. 2019;40(2):267–75.CrossRefPubMedPubMedCentral Ozutemiz C, Roshan SK, Kroll NJ, Benson JC, Rykken JB, Oswood MC, et al. Acute toxic leukoencephalopathy: etiologies, imaging findings, and outcomes in 101 patients. AJNR Am J Neuroradiol. 2019;40(2):267–75.CrossRefPubMedPubMedCentral
18.
go back to reference Jeyaraman VA, Sudharshan S, Selvakumar A, Bassi S, Noronha OV, Selvamuthu P, et al. Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection. J Ophthalmic Inflamm Infect. 2013;3(1):3.CrossRefPubMedPubMedCentral Jeyaraman VA, Sudharshan S, Selvakumar A, Bassi S, Noronha OV, Selvamuthu P, et al. Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection. J Ophthalmic Inflamm Infect. 2013;3(1):3.CrossRefPubMedPubMedCentral
19.
go back to reference Rae W, Kitley J, Pinto A. Selenium toxicity associated with reversible leukoencephalopathy and cortical blindness. JAMA Neurol. 2018;75(10):1282–3.CrossRefPubMed Rae W, Kitley J, Pinto A. Selenium toxicity associated with reversible leukoencephalopathy and cortical blindness. JAMA Neurol. 2018;75(10):1282–3.CrossRefPubMed
20.
go back to reference Casanova B, Prieto M, Deya E, Gisbert C, Mir J, Berenguer J, et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. Liver Transpl Surg. 1997;3(6):638–40.CrossRefPubMed Casanova B, Prieto M, Deya E, Gisbert C, Mir J, Berenguer J, et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. Liver Transpl Surg. 1997;3(6):638–40.CrossRefPubMed
21.
go back to reference Carroll JJ, Lavine SD, Meyers PM. Imaging of subdural hematomas. Neurosurg Clin N Am. 2017;28(2):179–203.CrossRefPubMed Carroll JJ, Lavine SD, Meyers PM. Imaging of subdural hematomas. Neurosurg Clin N Am. 2017;28(2):179–203.CrossRefPubMed
22.
go back to reference Gaucher DJ, Perez JA. Subdural hematoma following lumbar puncture. Arch Intern Med. 2002;162(16):1904–5.CrossRefPubMed Gaucher DJ, Perez JA. Subdural hematoma following lumbar puncture. Arch Intern Med. 2002;162(16):1904–5.CrossRefPubMed
23.
go back to reference McKeag H, Christian CW, Rubin D, Daymont C, Pollock AN, Wood J. Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces. J Neurosurg Pediatr. 2013;11(4):438–44.CrossRefPubMedPubMedCentral McKeag H, Christian CW, Rubin D, Daymont C, Pollock AN, Wood J. Subdural hemorrhage in pediatric patients with enlargement of the subarachnoid spaces. J Neurosurg Pediatr. 2013;11(4):438–44.CrossRefPubMedPubMedCentral
Metadata
Title
Paracetamol overdose associated with cortical blindness-complicated acute leukoencephalopathy: a case report
Authors
Ruba Khasawneh
Nour Keewan
Samah K. Aburahma
Basel Waleed Khurfan
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-024-00910-z

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more